glutathione for macular degeneration Our Science – Nacuity Pharmaceuticals Diseases Linked to LOW GLUTATHIONE
Description
A Hypothesis

Zaman M, Muslim M, Jehangir A

doi: 10.1038/s41591-020-0926-0 224 JohnsonDBNixonMJWangYWangDYCastellanosEEstradaMVet al

ByresEPatonAWPatonJCLflingJCSmithDFWilceMCet alIncorporation of a non-human glycan mediates human susceptibility to a bacterial toxin

Currently, treatments based on copper metabolism in cardiovascular disease can encompass a wide range of options, including copper chelating agents [such as triethylenetetramine (TETA), tetrathiomolybdate (TTM) and disodium ethylene diamine tetraacetic acid (EDTA)], small-molecule inhibitors of copper chaperone proteins (such as DCAL50), copper ion carriers and natural antidote agents (Table II)

K., et al., Subacute Inhalation Toxicity Study of Synthetic Amorphous Silica Nanoparticles in SpragueDawley Rats, Inhalation Toxicology 29 (2017): 567576
